POSB99 The Cost-Effectiveness of Biologic/Targeted Synthetic/Biosimilar Disease Modifying Antirheumatic Drugs: A Systematic Review

Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.372
https://www.valueinhealthjournal.com/article/S1098-3015(21)02167-7/fulltext
Title : POSB99 The Cost-Effectiveness of Biologic/Targeted Synthetic/Biosimilar Disease Modifying Antirheumatic Drugs: A Systematic Review
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02167-7&doi=10.1016/j.jval.2021.11.372
First page :
Section Title :
Open access? : No
Section Order : 11151
Categories :
Tags :
Regions :
ViH Article Tags :